Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-07-24FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD. [NA]
Clinical trial comparing FFR-guided revascularization to a conventional strategy in acute STEMI patients with multivessel disease has comple…
-
FDA approval · 2020-07-17FDA Approved: CLOPIDOGREL — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approves Polygen Pharmaceuticals' original ANDA for a generic clopidogrel product.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) [Phase 2]
Phase 2 clinical trial update for the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) completed.
-
FDA approval · 2020-07-15FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' generic heparin sodium (Original Application) as an injectable anticoagulant. It covers the same indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis [Phase 2]
Phase 2 clinical trial update for a PET imaging tracer targeting myocardial angiogenesis in acute myocardial infarction.
-
FDA approval · 2020-07-10FDA Approved: VALSARTAN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for VALSARTAN by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients [Phase 3]
Phase 3 trial update on preemptive lung impedance-guided therapy in evolving acute heart failure following acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction [Phase 2]
Phase 2 trial update for CSL112 in adults with moderate renal impairment and acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial [Phase 4]
Phase 4 safety pilot trial evaluating hydroxychloroquine for prevention of cardiovascular events in patients with myocardial infarction or a…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction [Phase 2, Phase 3]
Phase 2/3 trial evaluating bone marrow mesenchymal stem cell transfer in patients with ST-elevation myocardial infarction has completed.
-
CLINICAL_TRIALS research · 2020-05-13Clinical Trial Update: Novel Biomarkers of Thrombotic Risk
Clinical trial update reporting novel biomarkers associated with thrombotic risk in patients with myocardial infarction. Completed with resu…
-
FDA approval · 2020-05-05FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved Jubilant Cadista's supplemental application for the generic drug valsartan. Valsartan is used to treat hypertension, heart …
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation [Phase 4]
Phase 4 clinical trial update evaluating antiplatelet therapy in patients undergoing transcatheter aortic valve implantation (TAVI).
-
FDA approval · 2020-04-29FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals, advancing an update to an e…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Sevoflurane and Percutaneous Coronary Intervention by Stent [Phase 4]
Phase 4 clinical trial about sevoflurane during percutaneous coronary intervention for myocardial infarction has been terminated.
-
FDA approval · 2020-04-27FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC, approving a generic lisinopril product.
-
FDA approval · 2020-04-27FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for lisinopril submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2020-04-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Enalapril maleate from Northstar RxLLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Early Treatment of ARNI on Myocardial Remodeling and Progress [Phase 4]
Phase 4 trial update on early treatment with ARNI addressing myocardial remodeling after myocardial infarction.
-
FDA label_change · 2020-04-08FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for valsartan from Macleods Pharmaceuticals Limited, indicating changes to the product labeling.
-
FDA approval · 2020-04-07FDA Approved: TICAGRELOR — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for ticagrelor from Novadoz Pharmaceuticals LLC. Ticagrelor is an antiplatelet medication used to redu…
-
FDA approval · 2020-04-06FDA Approved: TICAGRELOR — Original Application (Oryza Pharmaceuticals, Inc.)
FDA approved the original application for ticagrelor by Oryza Pharmaceuticals, Inc., authorizing a generic ticagrelor product. Ticagrelor is…
-
FDA approval · 2020-04-02FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application for a generic heparin sodium product.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI [Phase 4]
Phase 4 study assessing the effects of atorvastatin on myocardial deformation in patients with myocardial infarction has completed.